Livzon Pharmaceutical Group Inc. (SHE:000513)

China flag China · Delayed Price · Currency is CNY
35.78
-0.03 (-0.08%)
At close: Dec 5, 2025
-4.38%
Market Cap 29.53B
Revenue (ttm) 11.85B
Net Income (ttm) 2.14B
Shares Out 887.91M
EPS (ttm) 2.38
PE Ratio 15.00
Forward PE 13.79
Dividend 1.10 (3.07%)
Ex-Dividend Date Jun 13, 2025
Volume 5,145,600
Average Volume 5,237,062
Open 35.82
Previous Close 35.81
Day's Range 35.35 - 35.83
52-Week Range 32.94 - 44.87
Beta 0.33
RSI 41.85
Earnings Date Mar 29, 2026

About SHE:000513

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally. The company offers leuprorelin acetate microspheres, urofollitropin, and menotropins for injection for the assisted reproduction field; Ilaprazole enteric-coated tablets, ilaprazole sodium for injection, and bismuth potassium citrate products for the gastrointestinal field; fluvoxamine maleate and perospirone hydrochloride... [Read more]

Sector Healthcare
Founded 1985
Employees 9,067
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000513
Full Company Profile

Financial Performance

In 2024, SHE:000513's revenue was 11.81 billion, a decrease of -4.97% compared to the previous year's 12.43 billion. Earnings were 2.06 billion, an increase of 5.50%.

Financial Statements

News

There is no news available yet.